Latest / Daniel and Kelly’s Extraordinary Universe / Addiction (featuring Dr. Marcelo Wood)
Transcript
- 0:00Speaker 1: Howdy, Extraordinaries!
- 0:01Speaker 2: As you might expect from the title of the episode,
- 0:03Speaker 2: today we're talking about addiction. We're going to be talking
- 0:06Speaker 2: about sensitive topics like drug use, drug abuse, and suicide.
- 0:11Speaker 2: So please decide now if this episode is a good
- 0:13Speaker 2: fit for you or for kiddos who might be within earshot.
- 0:24Speaker 2: According to the Substance Abuse and Mental Health Services Administration,
- 0:28Speaker 2: In 2024, among people 12 and older, about 17% of us,
- 0:33Speaker 2: or nearly 50 million people in the United States, struggled
- 0:37Speaker 2: with addiction. What is it that drugs do to our
- 0:40Speaker 2: brains that make them so addictive? And why is it
- 0:43Speaker 2: that some of us can try these drugs once and
- 0:45Speaker 2: then leave them alone, while others of us become hooked?
- 0:49Speaker 2: And what happens to our brains long-term after we've become
- 0:52Speaker 2: addicted to a drug of abuse? Well, it wouldn't be
- 0:55Speaker 2: an episode of DKEU if we didn't say, we don't know,
- 0:59Speaker 2: at least a few times throughout the episode. But today,
- 1:02Speaker 2: we're bringing on a guest who will give us the
- 1:04Speaker 2: latest insights into our understanding of addiction.
- 1:08Speaker 1: Welcome to Daniel and Kelly's Addictive Universe.
- 1:10Speaker 3: Addictive Universe Hi, I'm Daniel.
- 1:24Speaker 4: I'm a particle physicist who likes to think and write
- 1:27Speaker 4: about aliens, and I have several very healthy, habit-forming, non-addictive behaviors.
- 1:33Speaker 1: Hello, I'm Kelly Wienersmith.
- 1:34Speaker 2: I study parasites and space, and I certainly have the
- 1:37Speaker 2: kind of personality where I worry that if I.
- 1:39Speaker 1: Were to ever try a bad drug that I could
- 1:42Speaker 1: get addicted.
- 1:43Speaker 4: Really? All right, so my question for you today, Kelly,
- 1:45Speaker 4: is what is something in your life that you've given up?
- 1:49Speaker 1: That I've given up?
- 1:51Speaker 4: Other than cleaning Zach's office.
- 1:54Speaker 3: Oh, man.
- 1:54Speaker 1: Yeah, I threw my hands up at that one.
- 1:55Speaker 2: He actually, he told me the other day that it's
- 1:59Speaker 2: not fair that we keep harping on the Doritos bag
- 2:01Speaker 2: because he did clean that up.
- 2:04Speaker 1: But the rest of the office.
- 2:07Speaker 4: The point of those jokes is not the Doritos bag specifically.
- 2:10Speaker 4: It's what the Doritos bag stands for.
- 2:12Speaker 1: Represents.
- 2:13Speaker 2: I know.
- 2:13Speaker 1: I think he's missing the point there. But let's see.
- 2:16Speaker 1: What did I give up?
- 2:18Speaker 2: There was a time where I was having a glass
- 2:20Speaker 2: of wine every night.
- 2:22Speaker 1: And then it was two glasses of wine.
- 2:24Speaker 2: And then I realized I was starting to think about
- 2:25Speaker 2: how I was really looking forward to the glasses of wine.
- 2:29Speaker 2: And then I started thinking about my family history and
- 2:32Speaker 2: our relationship with alcohol.
- 2:33Speaker 1: Not my parents.
- 2:34Speaker 2: They both make great choices about alcohol. But a couple
- 2:37Speaker 2: generations out from that. And I decided I don't need
- 2:41Speaker 2: a glass of wine at night. And so I stopped
- 2:44Speaker 2: my evening glass of wine. I'll still have a glass
- 2:46Speaker 2: of wine sometimes if I go out to dinner with
- 2:47Speaker 2: friends or something. But I felt myself drifting in a
- 2:51Speaker 2: direction that I felt was maybe not the right direction
- 2:54Speaker 2: for me.
- 2:55Speaker 1: What about you?
- 2:56Speaker 4: Yeah, I have friends who feel the same way and
- 2:58Speaker 4: they do things like dry January where they're just like,
- 3:01Speaker 4: I'm just going to not have any for a month
- 3:02Speaker 4: just to prove to myself that I can.
- 3:05Speaker 3: Yeah.
- 3:05Speaker 4: And, uh, in my case, that was never something I
- 3:07Speaker 4: was doing all the time, but there was a period
- 3:09Speaker 4: in my life when I was, um, enjoying banana peels
- 3:13Speaker 4: quite regularly. And I decided, you know what, I'm going
- 3:16Speaker 4: to see if I can take a break. And I
- 3:18Speaker 4: did about six or seven years ago and, um, still
- 3:22Speaker 4: on that break.
- 3:24Speaker 2: Did you feel better when you went on that break
- 3:26Speaker 2: or was it, why are you still on that break?
- 3:28Speaker 4: Yeah, no good reason. I just, uh, didn't feel like
- 3:31Speaker 4: going back. I mean, um, Maybe I have fewer crazy
- 3:34Speaker 4: ideas to inspire my research, but....
- 3:38Speaker 1: You're still doing all right. You're still doing all right.
- 3:40Speaker 4: I'm still doing all right. When I start running out
- 3:43Speaker 4: of research ideas, then I'll dip back into that. But
- 3:47Speaker 4: until then, I'm staying clean.
- 3:49Speaker 5: All right.
- 3:49Speaker 1: Well, I think you could just go on a jog
- 3:50Speaker 1: and that might That might help you.
- 3:52Speaker 4: That's Kelly's answer to everything. Have you tried jogging?
- 3:56Speaker 2: Have you got on a jog? And the funny thing
- 3:58Speaker 2: is I haven't jogged. I've given up jogging apparently because
- 4:01Speaker 2: I haven't done that in a while. I've just been
- 4:03Speaker 2: too busy. I got to get back to jogging.
- 4:05Speaker 4: But exercise is a fascinating one because there are people
- 4:07Speaker 4: who exercise very regularly and are addicted to it to
- 4:11Speaker 4: the point where like, maybe it's not so healthy. It's
- 4:14Speaker 4: okay to take a day off kind of a thing.
- 4:16Speaker 3: Yeah. Yeah.
- 4:17Speaker 4: It's fascinating. Where even healthy seeming habits can be overdone.
- 4:21Speaker 1: Yeah, yeah.
- 4:22Speaker 2: I think it depends a lot on your personality. I
- 4:25Speaker 2: certainly am capable of overdoing.
- 4:27Speaker 1: Just about everything.
- 4:28Speaker 2: And in a lot of cases, I can funnel that
- 4:30Speaker 2: towards productive activities where it doesn't do me too much harm.
- 4:33Speaker 2: But I think I've been lucky in that way.
- 4:35Speaker 4: But enough of our clueless speculation. Neither of us are
- 4:38Speaker 4: giving you advice about how to live your life. And
- 4:40Speaker 4: we're not medical doctors, so we shouldn't be talking about this. Instead,
- 4:43Speaker 4: we decided to invite somebody on the show who does
- 4:45Speaker 4: know what they're talking about and can give us the
- 4:48Speaker 4: actual cutting edge scientific basis for addiction.
- 4:52Speaker 2: Yes, and our motivation for doing this, in addition to
- 4:54Speaker 2: just happening to know a person who studies addiction and
- 4:57Speaker 2: is awesome, is that we had two questions from listeners
- 5:00Speaker 2: focused on addiction. And so let's go ahead and listen
- 5:02Speaker 2: to those questions now.
- 5:04Speaker 3: Hey, Daniel and Kelly.
- 5:05Speaker 5: Greetings from beautiful Kombucha Ridge, Blacksburg, Virginia. I've got a
- 5:09Speaker 5: question for y'all, which is mostly for Kelly this time,
- 5:12Speaker 5: and it's about addiction. If I don't drink my coffee
- 5:15Speaker 5: in the morning, I get a gnarly headache.
- 5:17Speaker 4: Why is this?
- 5:18Speaker 5: Being addicted to coffee seems like it may be overall
- 5:21Speaker 5: good for human health, so continuing my morning ritual isn't
- 5:24Speaker 5: much of an internal struggle. However, for addictions that are
- 5:27Speaker 5: detrimental to our health, what is the mechanism that causes
- 5:31Speaker 5: otherwise rational people to continue these self-destructive habits, like tobacco
- 5:36Speaker 5: or other more nefarious substances? Thanks as always for your
- 5:39Speaker 5: awesome pods. Can't wait to hear y'all break it down.
- 5:41Speaker 3: Hi, Kelly and Daniel.
- 5:44Speaker 6: I guess my question distills down to why we get
- 5:47Speaker 6: addicted to sugar when it's so harmful to us in
- 5:52Speaker 6: so many ways and how is that if ketones are
- 5:56Speaker 6: so good for you and make you feel so much
- 5:59Speaker 6: better how is it nobody seems to be addicted to
- 6:03Speaker 6: ketones that'd be an interesting one for.
- 6:06Speaker 4: Me and one of my favorite things about living in
- 6:09Speaker 4: the sort of faculty ghetto at UC Irvine is that
- 6:12Speaker 4: I just happen to know people nearby who study this
- 6:15Speaker 4: and that and the other thing and so They're a
- 6:17Speaker 4: great resource because also they're too polite to say no
- 6:20Speaker 4: when we invite them on the podcast.
- 6:22Speaker 1: Hooray!
- 6:23Speaker 2: So let's go ahead and get our guest who couldn't
- 6:25Speaker 2: say no on the show.
- 6:29Speaker 3: Dr.
- 6:29Speaker 2: Marcella Wood is a professor and chair of the Neurobiology
- 6:32Speaker 2: and Behavior Department at the University of California, Irvine. His
- 6:35Speaker 2: lab works on understanding what's happening in our brains when
- 6:38Speaker 2: we form long-term memories with the goal of helping us
- 6:41Speaker 2: combat memory loss related to aging and neurogenerative.
- 6:44Speaker 1: Diseases like Alzheimer's.
- 6:45Speaker 2: His lab also explores how drug abuse impacts memory circuits
- 6:49Speaker 2: in the brain and seeks to use this information to
- 6:51Speaker 2: help prevent relapse.
- 6:53Speaker 1: Welcome to the show.
- 6:54Speaker 3: Thank you so much. It's a pleasure to be here.
- 6:56Speaker 2: Well, the first question that I really need to know
- 6:59Speaker 2: the answer to is that I wrote Daniel and Katrina
- 7:02Speaker 2: to be like, do you all know anyone who studies addiction?
- 7:04Speaker 2: And they were like, our neighbor studies addiction. So the
- 7:07Speaker 2: first thing I need to know is what is it
- 7:09Speaker 2: like living next to Daniel and Katrina? And is it
- 7:13Speaker 2: a problem that they are members of this weekly bean club?
- 7:18Speaker 3: It's fantastic living next to each other.
- 7:19Speaker 1: Okay, that's great.
- 7:22Speaker 3: Absolutely. Oh, that's it?
- 7:23Speaker 1: No insights?
- 7:24Speaker 3: Yeah.
- 7:25Speaker 4: Our boys used to play a lot in the street
- 7:27Speaker 4: behind our house. That's true. And I remember going over
- 7:30Speaker 4: there like, Silas, it's time to come home. It's dinner time.
- 7:33Speaker 4: And he's like, no, I need a drink of water.
- 7:35Speaker 4: And I'd be like, well, we have water at home.
- 7:36Speaker 4: And he's like, the water at Marcella's house is so
- 7:38Speaker 4: much better.
- 7:39Speaker 3: Okay. I did not know that. That's great.
- 7:44Speaker 4: We actually left a Google review on your house saying
- 7:47Speaker 4: the water here is excellent. Yeah, five stars.
- 7:49Speaker 3: That is hilarious. All right.
- 7:52Speaker 1: All right.
- 7:53Speaker 2: We'll transition into more serious topics. So we had a
- 7:56Speaker 2: handful of listener questions specifically about addiction, but they were
- 8:00Speaker 2: asking about different kinds of addiction.
- 8:02Speaker 4: Sure.
- 8:02Speaker 1: But let's start with just like, what is the general
- 8:04Speaker 1: definition of addiction? Yeah.
- 8:07Speaker 3: So first, in order to understand addiction and put it
- 8:10Speaker 3: into its context, I like to think about what our brain...
- 8:13Speaker 3: actually evolved to do and why drugs of abuse do
- 8:16Speaker 3: what they do. And so to kind of put it
- 8:19Speaker 3: into the right context, it's useful to think of the
- 8:22Speaker 3: reward system and the reward circuitry in your brain. What
- 8:25Speaker 3: does it do? What is it there for? How did
- 8:27Speaker 3: it evolve? And basically the reward circuitry in our brain
- 8:32Speaker 3: has evolved and designed to allow us to remember and
- 8:37Speaker 3: respond to things that we did right. So things that
- 8:41Speaker 3: are good for our own survival, and the survival of
- 8:45Speaker 3: our species. So those two things are critically, critically important.
- 8:50Speaker 3: And our brain has evolved to meet that requirement.
- 8:54Speaker 4: So my brain is rewarding me for buying that chocolate
- 8:56Speaker 4: bar at Trader Joe's because it's good for all of humanity,
- 8:59Speaker 4: you're saying.
- 8:59Speaker 3: Potentially. Depends on what chocolate means to you. And I agree.
- 9:04Speaker 3: Chocolate means a lot to me. So for example, things
- 9:09Speaker 3: like food, sex... social bonding, all those kinds of things,
- 9:16Speaker 3: if we do correctly, our brain rewards us for it
- 9:19Speaker 3: and uses a neurotransmitter called dopamine to say, hey, yeah,
- 9:25Speaker 3: we did this thing and we need to do that
- 9:27Speaker 3: again because it was really good. And dopamine release in
- 9:31Speaker 3: the reward circuitry is our motivator. It's telling us, yeah,
- 9:36Speaker 3: we did the right thing at the right time and
- 9:39Speaker 3: we need to remember that. And so the reward circuitry
- 9:42Speaker 3: in the brain is intimately tied in with the learning
- 9:45Speaker 3: and memory circuitry. So that's why my lab works on
- 9:48Speaker 3: both of these things together. You can't dissociate addiction and
- 9:52Speaker 3: reward behaviors from learning and memory. They're intimately tied together.
- 9:57Speaker 4: That seems so obvious now because rewards... only work if
- 10:01Speaker 4: you remember them, right?
- 10:02Speaker 3: Yeah, exactly. And so we do something right and our
- 10:07Speaker 3: brain releases dopamine and the dopamine levels change how the
- 10:12Speaker 3: neurons in our brain talks to each other. And then
- 10:15Speaker 3: those signals then go to the prefrontal cortex in our
- 10:18Speaker 3: brain That's our decision-making area. And it says, okay, yeah,
- 10:22Speaker 3: what we did was great. We're going to do that again,
- 10:25Speaker 3: or we're going to plan how to do it again.
- 10:27Speaker 3: So we can try and travel into the future and say,
- 10:30Speaker 3: in the past, we did this right. Now in the future,
- 10:33Speaker 3: we're going to do it right again. And it's good
- 10:34Speaker 3: for us. So that's the kind of foundational context of
- 10:38Speaker 3: what your brain does. And then drugs of abuse, unfortunately,
- 10:43Speaker 3: tap into all of that. And so drugs of abuse
- 10:46Speaker 3: and different drugs have different mechanism of action, but what
- 10:50Speaker 3: they all do is they hijack that reward circuitry. And
- 10:55Speaker 3: then they trick your brain into thinking, whatever that was,
- 10:58Speaker 3: that was 10 times better, a thousand times better, a
- 11:01Speaker 3: million times better than food, than sex, than social bonding,
- 11:06Speaker 3: all these natural rewards. And so now the brain sends
- 11:10Speaker 3: that signal to the prefrontal cortex for decision-making and it says, Well,
- 11:14Speaker 3: whatever that was, the neurotransmitter levels were so different and
- 11:18Speaker 3: so important that now we have to pursue that. That
- 11:22Speaker 3: has to be better for us. It has to be
- 11:24Speaker 3: better for our survival, the species, etc. Because the neurotransmitter
- 11:30Speaker 3: levels change so much. And so that's what grabs your brain.
- 11:34Speaker 2: So I'm thinking of a drug like cocaine and cocaine,
- 11:37Speaker 2: like the plants that cocaine comes from, maybe don't benefit
- 11:41Speaker 2: from us getting addicted to them.
- 11:43Speaker 1: Although maybe we do.
- 11:44Speaker 2: Maybe we grow a lot more cocaine plants because we're addicted.
- 11:46Speaker 2: But like, why does cocaine have this compound that does
- 11:50Speaker 2: this to our brain? Is that because it benefits cocaine
- 11:53Speaker 2: plants in some way and they're hijacking our brain for
- 11:55Speaker 2: their own benefit? Or is it just like this just
- 11:57Speaker 2: was an unhappy coincidence?
- 11:59Speaker 3: Yeah, that's a fantastic question that I have actually never
- 12:01Speaker 3: been asked. Hmm. So cocoa plants, they grow naturally all
- 12:07Speaker 3: throughout South America, four or five different countries that have
- 12:10Speaker 3: huge production. And the cocoa plants have that base compound
- 12:15Speaker 3: for cocaine. It's very, very little in the leaves. And
- 12:19Speaker 3: perhaps by animals chewing on that and then getting a
- 12:22Speaker 3: very little bit of sensation of, yeah, that's great, that
- 12:26Speaker 3: helps that plant propagate. I don't know, actually.
- 12:30Speaker 5: Okay.
- 12:30Speaker 4: So you've described how our brain... gives rewards in response
- 12:35Speaker 4: to certain behaviors and how some drugs can short circuit that,
- 12:39Speaker 4: giving you that reward or an enhanced version of that
- 12:42Speaker 4: reward without those behaviors. But what about the addiction part?
- 12:45Speaker 4: Like that describes how this is fun, this tastes good,
- 12:49Speaker 4: or this feels great. But isn't there more to addiction
- 12:52Speaker 4: than something about it that's biological or psychological?
- 12:55Speaker 3: Yeah, absolutely. And we can talk about this as this
- 12:59Speaker 3: conversation goes. It's really difficult. for people to understand what
- 13:03Speaker 3: drugs of abuse do and how it becomes a disorder.
- 13:07Speaker 3: And is it really a disorder? Some people actually argue
- 13:09Speaker 3: about is it a brain disorder or not? And the
- 13:12Speaker 3: reason comes back to what you asked, Daniel, that when
- 13:15Speaker 3: we first experience drugs of abuse, it's voluntary. It might
- 13:19Speaker 3: be a pain medication like opioids. Frequently, it starts with
- 13:23Speaker 3: pain management. But opioids, they do two things. One, they
- 13:29Speaker 3: release the brakes on that dopamine release and the dopamine
- 13:33Speaker 3: neuron function. So it's like releasing the emergency brake on
- 13:37Speaker 3: a car or not having brakes there. You can go
- 13:40Speaker 3: a lot faster. It's a lot better. The second thing
- 13:43Speaker 3: that opioids do is they engage hedonic feel-good response. So
- 13:49Speaker 3: with those two things in play, your brain has a
- 13:52Speaker 3: real hard time saying no to it. And it wants
- 13:55Speaker 3: it more. And so you start to... get this pattern
- 13:58Speaker 3: of continuously taking it and continuously seeking it. And some
- 14:03Speaker 3: people can still stop after months, years, a decade, they
- 14:08Speaker 3: can stop. But others continue down a more compulsive path.
- 14:13Speaker 3: Part of your reward circuitry has to do with habits
- 14:16Speaker 3: and compulsive habits and patterns of action. And so, that
- 14:21Speaker 3: part of the reward then starts to get rewired so
- 14:25Speaker 3: that someone starts to compulsively search and take drugs of
- 14:30Speaker 3: abuse like opioids. And then what happens is the brain
- 14:34Speaker 3: starts to compensate for that. So your brain does not
- 14:37Speaker 3: want to have dopamine release constantly flooding the neurons and
- 14:42Speaker 3: having the neurons constantly activated. It can become neurotoxic. So
- 14:48Speaker 3: your brain starts to decrease levels of the receptors where
- 14:52Speaker 3: the drugs bind to. So your brain decreases those receptors,
- 14:56Speaker 3: tries to fight this constant push by the drugs of abuse.
- 15:00Speaker 3: And then what happens is people start to have these
- 15:04Speaker 3: anhedonia type effects where normal rewards aren't pleasurable anymore. Food
- 15:10Speaker 3: is not pleasurable. Sex is not pleasurable. Even taking your
- 15:14Speaker 3: drug of abuse isn't pleasurable, but you're scratching that itch
- 15:17Speaker 3: to get it.
- 15:18Speaker 4: Wait, I never realized that. You're saying if you become
- 15:21Speaker 4: addicted or if you overstimulate, then other activities, which normally
- 15:26Speaker 4: would give you a pleasurable feeling, start to feel less fun?
- 15:30Speaker 3: Right. Oh my gosh. And this is a whole other conversation.
- 15:35Speaker 3: It's almost similar to what some people, not all people,
- 15:39Speaker 3: some people experience on GLP-1. GLP-1, which I don't know
- 15:44Speaker 3: if you've heard, has been affecting people that are addicted
- 15:47Speaker 3: to alcohol. And probably other drugs as well. Alcohol is
- 15:51Speaker 3: where the story first broke. And now there are clinical
- 15:54Speaker 3: trials trying to understand how does GLP-1 agonists affect alcohol
- 15:58Speaker 3: and drug pursuit. But there are some people that are
- 16:01Speaker 3: being affected because it affects dopamine function in the brain.
- 16:05Speaker 3: You don't feel like pursuing food anymore. But the other
- 16:09Speaker 3: consequence is you don't feel like pursuing other things either.
- 16:12Speaker 3: So you get anhedonic. There's the anhedonia, depression. And so
- 16:16Speaker 3: people are trying to figure out, is that a dose-dependent effect?
- 16:19Speaker 3: Is it a drug-specific effect? Like one company makes this
- 16:22Speaker 3: type of agonist, et cetera. So there are all these
- 16:26Speaker 3: competing things happening in the brain.
- 16:28Speaker 2: So is that like, if you're on GLP-1, you're not
- 16:32Speaker 2: only less interested in eating, but you're also less interested
- 16:35Speaker 2: in alcohol? Or are you more interested in alcohol?
- 16:38Speaker 3: Yes. Less. Yeah. Less. And it's not all people.
- 16:41Speaker 4: Okay.
- 16:42Speaker 3: It depends on a lot of factors, but there are
- 16:45Speaker 3: subsets of people that that's exactly what they feel. They
- 16:48Speaker 3: don't want to pursue food. They don't want to pursue alcohol,
- 16:51Speaker 3: but they don't want to pursue anything. That dopamine motivation
- 16:54Speaker 3: signal isn't coming through.
- 16:56Speaker 2: And are we able to predict like, you know, so
- 16:59Speaker 2: lots of people are prescribed opioids for pain. Some of
- 17:02Speaker 2: them become addicted. Some of them don't. And lots of
- 17:04Speaker 2: people get GLP-1s.
- 17:06Speaker 1: Some people.
- 17:07Speaker 2: become less interested in things like alcohol.
- 17:09Speaker 1: Some don't.
- 17:09Speaker 2: Can we predict how people are going to respond to
- 17:12Speaker 2: this stuff? Do we understand individual variability in this stuff?
- 17:15Speaker 3: Yeah, that's a great question. And that's a huge area
- 17:18Speaker 3: of investigation because in some aspects of basic research, it's
- 17:24Speaker 3: really hard to get at the genetics and the individual
- 17:26Speaker 3: genetic variability.
- 17:28Speaker 1: Mm-hmm.
- 17:29Speaker 3: On the other side, humans are highly variable. And we
- 17:34Speaker 3: can get into epigenetics, which my lab studies on, and
- 17:36Speaker 3: that speaks to persistence, but it also speaks to this
- 17:39Speaker 3: individual variability. And so, it's really hard to tie down
- 17:45Speaker 3: who might be susceptible and who might not be. That's
- 17:48Speaker 3: a great, great area of investigation right now in science.
- 17:52Speaker 4: You've sketched out this sort of cartoon version of how
- 17:55Speaker 4: the brain works. Thank you for making it accessible to us.
- 17:58Speaker 4: But I also wonder how much of that is our
- 18:02Speaker 4: speculation and how much of that is really grounded in
- 18:05Speaker 4: measurement and theory and understanding the brain itself, which to
- 18:09Speaker 4: my limited understanding remains a mystery, even at a fairly
- 18:13Speaker 4: basic level. Like, do we know how these things really
- 18:16Speaker 4: work at the neuronal level and the prefrontal cortex and
- 18:18Speaker 4: all that stuff?
- 18:19Speaker 5: Yeah, yeah.
- 18:20Speaker 3: So through basic research, Two things here. One, we know
- 18:24Speaker 3: that when classifying a drug of abuse as addictive, you
- 18:29Speaker 3: can go across species and you can see that almost
- 18:32Speaker 3: all species will self-administer a drug of abuse, like cocaine, opioids.
- 18:38Speaker 3: A lot of species will self-administer if given the opportunity
- 18:42Speaker 3: to do so.
- 18:43Speaker 4: So there are like labs out there that give rats
- 18:45Speaker 4: cocaine or like birds cocaine or.
- 18:48Speaker 5: Yeah.
- 18:50Speaker 3: And so because the rewards circuitry in the brain is
- 18:54Speaker 3: one of the oldest circuits in the brain. So, for example,
- 18:59Speaker 3: I'm working with a professor at UCLA right now trying
- 19:03Speaker 3: to understand how opioid neurotransmitter system evolved. So, one of
- 19:08Speaker 3: the things we're looking at are hagfish, which are one
- 19:10Speaker 3: of the oldest, oldest animals out there.
- 19:13Speaker 1: Slimiest.
- 19:15Speaker 5: Yeah.
- 19:15Speaker 4: Are those the ones that produce like incredible volumes of slime?
- 19:18Speaker 3: Yeah. So we're trying to sequence the DNA of hagfish
- 19:22Speaker 3: right now to understand how these gene sets evolve, duplicated, specialized.
- 19:28Speaker 4: And so I never thought I'd be asking this question,
- 19:30Speaker 4: but what does a hagfish do when it snorts cocaine?
- 19:32Speaker 3: That we don't know.
- 19:36Speaker 4: Somebody's got to do the experiment.
- 19:39Speaker 3: They have the receptors.
- 19:40Speaker 5: Yeah.
- 19:41Speaker 3: So going back to your question, A lot of the
- 19:44Speaker 3: mode of action has been well characterized. We know what
- 19:47Speaker 3: the receptors are. Once you identify the receptors, you can see, okay,
- 19:51Speaker 3: where are those receptors in the brain? So that then
- 19:54Speaker 3: starts to tell you the circuitry. And then people have
- 19:57Speaker 3: been studying the circuitry at many, many different levels. So
- 20:01Speaker 3: we know what brain regions, we know what cell types
- 20:04Speaker 3: in those brain regions, we know the acute chronic effects
- 20:08Speaker 3: of different drugs. All that is really well worked out.
- 20:12Speaker 3: I think one of the real unknown domains in addiction is, again,
- 20:17Speaker 3: coming back to what you asked, where does the persistence
- 20:20Speaker 3: come from? How is it that you can experience a
- 20:24Speaker 3: drug of abuse, for example, like methamphetamine, and that leaves
- 20:28Speaker 3: a molecular signature in your brain for decades?
- 20:32Speaker 4: Wow. Wow.
- 20:33Speaker 3: Right? How does that happen? And so there are very,
- 20:36Speaker 3: very few molecular mechanisms that can give you that, and
- 20:39Speaker 3: epigenetic mechanisms is one of those. And that can explain,
- 20:43Speaker 3: and I'll talk about epigenetics in a minute if you want,
- 20:45Speaker 3: but epigenetic mechanisms can explain how a single event or
- 20:50Speaker 3: a pattern of events can be encoded and stay persistently
- 20:54Speaker 3: encoded in the brain. And that happens throughout your body.
- 20:57Speaker 3: Your body uses these mechanisms for development and differentiation of
- 21:01Speaker 3: different cell types and tissues. So your brain uses these
- 21:05Speaker 3: mechanisms as well. But then somebody can be abstinent for
- 21:09Speaker 3: decades and then a certain cue, a signal, a context
- 21:15Speaker 3: will trigger the reward pathway to re-engage and the person
- 21:20Speaker 3: will seek the drug. But then because of absence of
- 21:25Speaker 3: the drug, the tolerance that they had developed a long
- 21:28Speaker 3: time ago isn't there anymore. And yet they will take
- 21:33Speaker 3: the same amount of drug that they used to, and
- 21:35Speaker 3: that is the kind of thing that leads to overdose deaths.
- 21:38Speaker 3: And so there are all these aspects of abstinence, what
- 21:41Speaker 3: happens during abstinence, how does that persist through decades? How
- 21:47Speaker 3: does relapse occur? How do we stop relapse? All those
- 21:51Speaker 3: kinds are the major open questions in the field of
- 21:54Speaker 3: substance use and use disorders.
- 21:56Speaker 1: And those are some pretty important questions.
- 21:58Speaker 3: Yeah.
- 21:59Speaker 2: We haven't on the show before talked about epigenetics, I
- 22:02Speaker 2: don't think. So could you go ahead and explain what
- 22:05Speaker 2: epigenetics is?
- 22:06Speaker 3: Yeah. So epi means above, and genetics, your genome. So
- 22:11Speaker 3: it's literally above the level of your DNA. So your
- 22:14Speaker 3: genome is your DNA. And your DNA, we know exactly
- 22:19Speaker 3: what that looks like. We can sequence every individual person's
- 22:23Speaker 3: DNA and we will know exactly what it looks like.
- 22:26Speaker 3: And your DNA has a very fixed level of information capacity.
- 22:33Speaker 3: And that encodes all your genes, how those genes are
- 22:36Speaker 3: turned on and when, and gives rise to our blueprint, right?
- 22:39Speaker 3: Our body, our function. But then the epigenome, it's a
- 22:45Speaker 3: collection of chemical modifications on the DNA that And the
- 22:49Speaker 3: proteins that wrap the DNA. So for example, if you
- 22:52Speaker 3: took just one cell of your body, you have 46
- 22:56Speaker 3: chromosomes in that one cell. And so that nucleus is
- 23:01Speaker 3: microscopic and has 46 chromosomes. So if you unravel those
- 23:06Speaker 3: chromosomes and put them head to tail, you would have
- 23:09Speaker 3: six feet of DNA.
- 23:10Speaker 1: That's crazy.
- 23:11Speaker 3: Six feet. Six feet. Wow. In this microscopic nucleus.
- 23:15Speaker 4: All rolled up inside every single cell. Amazing.
- 23:17Speaker 3: And so- The DNA gets wrapped around these proteins and compacted,
- 23:22Speaker 3: massively compacted. It's about a 10,000-fold level of compaction. If
- 23:28Speaker 3: you took a piece of paper and folded it in
- 23:29Speaker 3: half and folded that in half and that in half,
- 23:32Speaker 3: you can do that seven or eight times. This is 10,000-fold.
- 23:36Speaker 3: It's a number our brain can't really comprehend. And so
- 23:39Speaker 3: all your genes are in that tight little mix. And
- 23:42Speaker 3: so you have to access and turn on your genes
- 23:45Speaker 3: to And your epigenome does that. Your DNA is totally fixed.
- 23:49Speaker 3: So a liver cell has the exact same DNA as
- 23:52Speaker 3: a kidney cell. But a liver cell is only expressing
- 23:56Speaker 3: genes for liver function. Kidney cell is only expressing kidney genes.
- 24:01Speaker 3: All the other genes are repressed. They're shut down by
- 24:05Speaker 3: an epigenetic mechanism that controls this. So your epigenome controls
- 24:10Speaker 3: how your genes are turned on and off and regulated.
- 24:14Speaker 3: And here's the crazy part. Your DNA gets these little
- 24:18Speaker 3: chemical modifications. The protein that helps compact the DNA gets
- 24:23Speaker 3: little modifications. That whole collection of modifications is called your epigenome.
- 24:28Speaker 3: Every epigenetic modification is a metabolite. So our diet, our experience,
- 24:35Speaker 3: our sleep, our stress, the pesticides that we eat in
- 24:39Speaker 3: our food, all get integrated into that platform. And that's
- 24:43Speaker 3: how we adapt. Within our lifespan, right? So there's evolutionary
- 24:48Speaker 3: adaptation that takes eons. And then there's within-organismal adaptation to
- 24:54Speaker 3: your life experience. And the crazy thing is people think
- 24:58Speaker 3: that the epigenome can also be a source of heritable experience.
- 25:03Speaker 4: That you could pass it on to people. Right.
- 25:05Speaker 3: So things that your grandparents experienced would be epigenetically inherited
- 25:10Speaker 3: by you. And it can skip generations. So these are
- 25:13Speaker 3: all things that people don't understand. The phenomena have been observed.
- 25:17Speaker 3: They exist. But we don't understand the mechanism.
- 25:19Speaker 4: So if my grandparents had some amazing transformational chocolate bar
- 25:24Speaker 4: 100 years ago, that could have been somehow encoded and
- 25:27Speaker 4: passed down to me and led to me appreciating chocolate
- 25:30Speaker 4: even more?
- 25:31Speaker 3: Potentially. And so where they've shown that to be true
- 25:35Speaker 3: is with odors associated with fear responses. And so that
- 25:40Speaker 3: you can track within a species, but across generations. A
- 25:43Speaker 3: grandchild of a grandparent that had an odor associated with
- 25:49Speaker 3: a terrifying experience, they'll be weary of that odor for
- 25:54Speaker 3: no reason. They've never experienced the fear component.
- 25:56Speaker 4: Wow.
- 25:57Speaker 3: But we don't know how that works.
- 25:58Speaker 2: I remember I had read about, I think it was
- 26:00Speaker 2: Michael Meany's experiments on how moms treated their babies and
- 26:04Speaker 2: how that impacted the way they responded to stress for
- 26:05Speaker 2: the rest of their lives. And I learned about that
- 26:07Speaker 2: right before I got pregnant. And every time I got
- 26:10Speaker 2: stressed out, I was like, no, I'm going to ruin
- 26:12Speaker 2: my daughter. And then that stressed me out even more.
- 26:15Speaker 2: And it was this like feedback. And eventually my husband
- 26:17Speaker 2: was like, you gotta, here's some ice cream, calm down.
- 26:19Speaker 1: And I was like, all right. And I'd feel better,
- 26:21Speaker 1: but all right, let's take a break.
- 26:24Speaker 2: And when we get back, we'll unpack epigenetics a little
- 26:27Speaker 2: bit more.
- 26:47Speaker 1: And we're back. And let's start with a question from Daniel.
- 26:50Speaker 4: So this idea of epigenetics and remembering things, Does that
- 26:54Speaker 4: mean that, for example, if somebody lives next to a
- 26:57Speaker 4: bunch of very nice bean eaters, that their children and
- 27:01Speaker 4: their children's children might have a particular response to the
- 27:06Speaker 4: aroma of digested beans?
- 27:10Speaker 1: Fear response?
- 27:11Speaker 3: Honestly, I don't know. Yeah.
- 27:16Speaker 4: All right.
- 27:16Speaker 3: That's hilarious, though.
- 27:18Speaker 4: That was a joke question, but I wanted to say
- 27:19Speaker 4: more about this sort of state-of-the-art-of-knowledge thing. about where this
- 27:22Speaker 4: information is stored. Because in the case of genetics, it's obvious,
- 27:25Speaker 4: it's the DNA, that's where it's stored. In the case
- 27:28Speaker 4: of epigenetics, you pointed to molecular fingerprints and the sort
- 27:32Speaker 4: of information around the genome. What is the context in
- 27:36Speaker 4: which this can be written and read and impact the
- 27:40Speaker 4: behavior and the life of a creature?
- 27:43Speaker 3: Where this is happening physically is on the DNA itself.
- 27:48Speaker 3: So DNA can obtain a modification called methylation. So the
- 27:52Speaker 3: DNA gets methylated. And that's just a little tiny chemical
- 27:57Speaker 3: group that gets added to DNA. And that tiny, tiny
- 28:00Speaker 3: little chemical group can absolutely change gene expression. It can
- 28:04Speaker 3: shut it down, or in some cases, it can help
- 28:06Speaker 3: turn it on. So an excellent example of this is
- 28:10Speaker 3: going back to pregnancy, Kelly. Mm-hmm. When a mom is pregnant,
- 28:14Speaker 3: she'll frequently be prescribed supplemental folic acid, right? And so
- 28:20Speaker 3: a lot of moms will take supplemental folic acid. And
- 28:23Speaker 3: the reason is folic acid is a methyl donor. That
- 28:27Speaker 3: little chemical group that gets added to DNA, it's a
- 28:30Speaker 3: methyl donor. And so folic acid supplementation prevents spina bifida.
- 28:36Speaker 3: And so you have normal spinal cord development and whatnot
- 28:39Speaker 3: when you've supplemented. You prevent any potential harm from malnutrition
- 28:44Speaker 3: or not having enough of the right type of nutrients
- 28:47Speaker 3: for that epigenetic mechanism to be engaged. Another example of
- 28:51Speaker 3: that is with rheumatoid arthritis. When you have severe rheumatoid arthritis,
- 28:57Speaker 3: you get put on a drug called methotrexate. It's an anti-inflammatory,
- 29:01Speaker 3: helps people quite a bit. But usually insurance companies require
- 29:05Speaker 3: people to be on it for a couple of years
- 29:07Speaker 3: before they get moved on to biologicals like antibodies, which
- 29:10Speaker 3: work better. So methotrexate, one of the problems is it
- 29:13Speaker 3: causes memory formation problems. And the reason is methotrexate is
- 29:19Speaker 3: affecting that DNA methylation pool. And so people that are
- 29:23Speaker 3: on methotrexate will frequently supplement with folic acid for their memory.
- 29:28Speaker 3: So these epigenetic mechanisms are heavily used during development. And
- 29:33Speaker 3: they're also heavily used by our adult brain past development
- 29:38Speaker 3: and those physical entities exist on the DNA itself, as
- 29:42Speaker 3: well as the proteins that the DNA wraps around to
- 29:44Speaker 3: get compacted into the nucleus of a cell.
- 29:47Speaker 2: Is there ever a good reason for your brain to
- 29:51Speaker 2: be less good at forming memories?
- 29:53Speaker 1: Or is this always.
- 29:53Speaker 2: Just you have a deficit of something you need, and
- 29:56Speaker 2: that's why you have the problem and you have to
- 29:58Speaker 2: take folic acid?
- 29:59Speaker 3: Brilliant question. So for the longest time, my lab, we
- 30:03Speaker 3: were obsessed with trying to understand how are long-term memories
- 30:06Speaker 3: formed and how do they persist? And we thought if
- 30:09Speaker 3: we can answer that question, we can understand things like PTSD, addiction,
- 30:13Speaker 3: et cetera. And after about 10 years of work, we
- 30:16Speaker 3: realized that we had accidentally discovered the opposite. We had
- 30:20Speaker 3: discovered enzymes that control epigenetic machinery that prevent you from
- 30:27Speaker 3: encoding everything. And we found out by accident because when
- 30:30Speaker 3: we mess with those enzymes, animals can encode sub-threshold learning events.
- 30:37Speaker 3: Learning events that would not be encoded into long-term memory
- 30:39Speaker 3: are perfectly encoded into long-term memory and persistently. And so
- 30:44Speaker 3: when you modulate the epigenetic machinery, you absolutely massively control
- 30:50Speaker 3: learning and memory.
- 30:51Speaker 1: Wow.
- 30:52Speaker 3: And again, that's what drugs of abuse do as well.
- 30:55Speaker 3: And so going back to what you asked with the memory,
- 30:59Speaker 3: Our brain is very selective at what it encodes. And
- 31:03Speaker 3: we do not want it encoding everything. We want it
- 31:07Speaker 3: to encode the most important things that happen to us.
- 31:12Speaker 3: For example, if you're crossing the street and you're jaywalking
- 31:16Speaker 3: and you almost get hit by a car, your brain
- 31:18Speaker 3: will instantly encode that event. It will release a stress hormone.
- 31:23Speaker 3: The stress hormone immediately engages the epigenetic machinery. adjust it
- 31:27Speaker 3: so that you kick on gene expression that allows your
- 31:30Speaker 3: neurons to change their structure and function and they encode
- 31:34Speaker 3: everything that you experienced that day. What kind of car
- 31:36Speaker 3: almost killed you, what you were wearing that day, what
- 31:39Speaker 3: you had for breakfast, whoever remembers that, unless you eat
- 31:42Speaker 3: the exact same thing like I do every single breakfast,
- 31:45Speaker 3: what street it was, what time of the day, you
- 31:48Speaker 3: encode all that. It's a flash memory. But normally that
- 31:51Speaker 3: doesn't happen. Normally it's very difficult for us to encode things.
- 31:55Speaker 3: So like, med students going through organic chemistry. It's awful
- 32:00Speaker 3: trying to memorize all that organic chemistry. Your brain isn't
- 32:03Speaker 3: designed to do that. It doesn't want to do that.
- 32:05Speaker 3: So it takes repetitive, spaced out training to be able
- 32:08Speaker 3: to encode things like that.
- 32:10Speaker 4: It is awful.
- 32:11Speaker 3: Totally agree.
- 32:12Speaker 1: You took organic chemistry as a physicist?
- 32:15Speaker 3: Why did you do.
- 32:16Speaker 1: That to yourself?
- 32:17Speaker 4: I didn't take organic chemistry because it is awful.
- 32:20Speaker 3: Oh, I see.
- 32:20Speaker 4: But I think you're saying that it's good to be
- 32:23Speaker 4: able to forget things. Otherwise, we'd be like awash in
- 32:26Speaker 4: a bunch of boring details.
- 32:28Speaker 3: Yeah.
- 32:28Speaker 4: And we should be remembering the important stuff. That's the
- 32:30Speaker 4: answer to Kelly's question, is that there's a lot of
- 32:33Speaker 4: our lives that are forgettable, unfortunately.
- 32:35Speaker 3: Yeah. We would not be able to give the right
- 32:38Speaker 3: salience to things, whether good or bad. Everything would be
- 32:41Speaker 3: the same.
- 32:42Speaker 4: And this is something I don't think I understood before.
- 32:45Speaker 4: You're saying essentially that our personalities and our memories are
- 32:48Speaker 4: not just encoded in our neural structure. As a physicist
- 32:53Speaker 4: who thinks about machine learning and training and stuff, I
- 32:56Speaker 4: think about networks learning and all that is encoded in
- 32:58Speaker 4: the weights and the structure of the network. You're saying
- 33:01Speaker 4: it's more than just the neurons and the structure and
- 33:03Speaker 4: the relationships in our brain. There's this whole chemical overlay,
- 33:07Speaker 4: this epigenetic overlay that also affects our behavior because it
- 33:11Speaker 4: affects our memory. That's like totally brand new knowledge to
- 33:15Speaker 4: me today. Wow.
- 33:16Speaker 3: I remember a while ago reading a yeast genetics paper.
- 33:19Speaker 3: And so people studying yeast gave yeast a particular food source.
- 33:23Speaker 3: The yeast would use that food source and then it
- 33:27Speaker 3: engages transcription factors for the metabolic machinery to use the
- 33:30Speaker 3: food source. And then you take the food source away.
- 33:33Speaker 3: And there are all these epigenetic modifications that remain. And
- 33:37Speaker 3: so yeast geneticists would call that short-term or long-term memory,
- 33:40Speaker 3: depending on how long those chemical modifications on the epigenome lasted.
- 33:45Speaker 3: So then, well, why? Why would a yeast care about
- 33:48Speaker 3: that or a yeast geneticist care about that? It's because
- 33:51Speaker 3: that type of molecular memory then allows a yeast that
- 33:56Speaker 3: has experienced the food source once to experience it a
- 33:58Speaker 3: second time. Their metabolic machinery is ready to use it immediately.
- 34:02Speaker 3: And they can out-compete a naive yeast.
- 34:04Speaker 5: Wow.
- 34:05Speaker 3: So it gives them an adaptive advantage. And so that's
- 34:08Speaker 3: an epigenetic molecular memory that then allows that yeast to
- 34:13Speaker 3: have an adaptive advantage.
- 34:16Speaker 4: So I promise I'm going to get us back to addiction.
- 34:17Speaker 4: But first, I have to ask you a crazy-sounding question,
- 34:19Speaker 4: which is, so then if you read science fiction novels
- 34:22Speaker 4: where they're scanning people's brains and uploading them to the
- 34:25Speaker 4: cloud to live forever, are you thinking... You also got
- 34:28Speaker 4: to scan their epigenetics. Otherwise it's not the same person.
- 34:31Speaker 3: Oh, absolutely. Absolutely. Yeah.
- 34:34Speaker 2: You two need to collaborate on a sci-fi novel. So
- 34:40Speaker 2: to bring us back to addiction is, is the connection here.
- 34:42Speaker 2: So you mentioned that people who managed to get themselves
- 34:46Speaker 2: off of drugs of abuse years later can get triggered.
- 34:50Speaker 1: Is that epigenetics making that happen?
- 34:53Speaker 3: In part, in part for sure. So we know that
- 34:56Speaker 3: drugs of abuse and consistent use can change the circuitry
- 35:01Speaker 3: in a very persistent way. And we can measure those
- 35:04Speaker 3: changes in all sorts of ways. So we know that happens.
- 35:07Speaker 3: We know it's persistent. And one of the only ways
- 35:10Speaker 3: that cells can change their function and maintain that difference
- 35:14Speaker 3: is through epigenetic regulation. And that's what we see in development.
- 35:18Speaker 3: When we develop and our bodies develop, certain parts of
- 35:21Speaker 3: our body take on a specific function like the liver
- 35:24Speaker 3: or the kidney. and forevermore stay that function. And so
- 35:27Speaker 3: that's what's happening to the reward system. It's experienced this
- 35:31Speaker 3: drug of abuse for who knows how long. It's adapted
- 35:35Speaker 3: and changed persistently. And that fundamental change then puts the
- 35:39Speaker 3: brain at risk to relapse, either due to experience the
- 35:44Speaker 3: drug again, like having a drink after being sober for decades,
- 35:49Speaker 3: seeing a cue or a context, For a cocaine user,
- 35:52Speaker 3: that can be a rolled up dollar bill. It can
- 35:54Speaker 3: be a snow-capped mountain. It can trigger somebody with cocaine
- 35:58Speaker 3: use disorder.
- 35:59Speaker 4: You mean because they did cocaine on a snow-capped mountain
- 36:02Speaker 4: once before or because a snow-capped mountain looks like it
- 36:05Speaker 4: has cocaine on it?
- 36:05Speaker 3: It reminds them of the powder. Wow. Yeah.
- 36:09Speaker 4: Wow, fascinating. So then in your view, is addiction biological?
- 36:14Speaker 4: Is it psychological? Is there even a distinction? Is all
- 36:18Speaker 4: of psychology just biological?
- 36:20Speaker 3: Yeah, so I think it's a mix of that. I
- 36:23Speaker 3: spend most of my time studying it at a molecular
- 36:26Speaker 3: and epigenetic level, but there's absolutely a psychosocial component to it.
- 36:32Speaker 3: As humans, we are very social animals. And one thing
- 36:36Speaker 3: that in neuroscience still drives me insane is In neuroscience,
- 36:39Speaker 3: we always study an individual brain. Always. Whether it's animal research,
- 36:44Speaker 3: human research, it's an individual brain. But our brains never
- 36:47Speaker 3: evolved to work individually. Our brains evolved to interact with
- 36:51Speaker 3: other brains.
- 36:52Speaker 5: Always.
- 36:53Speaker 3: They're always interacting with other brains. And that's the success
- 36:56Speaker 3: of a species. And so, with addiction, it's not only
- 37:01Speaker 3: the chemical component and the molecular component, but there's a
- 37:05Speaker 3: very large social component to it as well. And it
- 37:09Speaker 3: has a genetic component as well. So the heritability of
- 37:13Speaker 3: addiction is the same as diabetes, hypertension. The genetic risk
- 37:20Speaker 3: is similar to those diseases. But people argue with addiction
- 37:27Speaker 3: being a disorder or a disease because you can have
- 37:32Speaker 3: addiction be part of your life for quite a long
- 37:34Speaker 3: time and then become abstinent. and never, ever return to
- 37:38Speaker 3: that drug of abuse. And that can't happen with Alzheimer's disease, right? Right.
- 37:43Speaker 3: Or Huntington's disease. If you have that disease, you don't
- 37:48Speaker 3: just stop all of a sudden. It doesn't just go away.
- 37:51Speaker 3: It will always be there. So people get into these
- 37:53Speaker 3: arguments of disease or not disease, etc.
- 37:57Speaker 4: So then is there a distinction in your mind between
- 37:59Speaker 4: things that are habit-forming and things that are addictive? Like
- 38:03Speaker 4: you just said that you can have addictions, which then
- 38:05Speaker 4: you just walk away from. So, for example, I eat
- 38:08Speaker 4: chocolate regularly. I don't think I'm addicted to chocolate. I've
- 38:11Speaker 4: gone for periods without doing chocolate.
- 38:14Speaker 1: Doing chocolate.
- 38:15Speaker 4: Doing chocolate. Hitting chocolate. Without my chocolate dealer coming to
- 38:22Speaker 4: my house. So, is there a distinction there between habit
- 38:25Speaker 4: forming and addiction? People also say, for example, marijuana is
- 38:29Speaker 4: not addictive. It's habit forming. Is that a meaningful distinction?
- 38:33Speaker 4: What does it mean?
- 38:34Speaker 3: Well, yeah. I have trouble with. splitting hairs like that
- 38:38Speaker 3: because people use these terms in different ways. But I
- 38:42Speaker 3: think undoubtedly part of the circuitry in the mesolimbic pathway
- 38:48Speaker 3: that is the reward circuitry, there's a habit component. And
- 38:52Speaker 3: we know from experiments that you can adjust those habit
- 38:56Speaker 3: mechanisms to transform into compulsive drug taking. And so although
- 39:03Speaker 3: habits and habit formation might be part of it. That's
- 39:08Speaker 3: all it is. It's just part of it. And it
- 39:10Speaker 3: might be in series with developing a compulsive disorder, but
- 39:15Speaker 3: it might not be. There's so many different components to this.
- 39:19Speaker 3: It's hard to tell what's a stronger driver in one
- 39:22Speaker 3: person versus another person.
- 39:23Speaker 4: So you're saying it is possible to have a healthy
- 39:28Speaker 4: relationship with chocolate and also to have chocolate every day.
- 39:32Speaker 3: I think so.
- 39:32Speaker 4: I want a scientific blessing for my chocolate habit here.
- 39:36Speaker 3: Having the same chocolate problem, uh, I want to believe
- 39:40Speaker 3: in that, too.
- 39:43Speaker 2: So now that you've gone into all of this nuance
- 39:46Speaker 2: to explain to us that like that social stuff also matters,
- 39:49Speaker 2: but I'm going to still try to go back and
- 39:51Speaker 2: simplify things for a second. So we've been trying to
- 39:54Speaker 2: look at how addiction impacts the brain.
- 39:57Speaker 1: Where are we in our.
- 39:58Speaker 2: Ability to use medications to try to tinker with the
- 40:02Speaker 2: brain to undo the damage that's been done? Five years
- 40:05Speaker 2: from now, will we be giving drug addicts a bunch
- 40:08Speaker 2: of folic acid or withholding folic acid because it was
- 40:11Speaker 2: an epigenetics thing? Where are we in being able to
- 40:14Speaker 2: give people medications to help with this kind of stuff?
- 40:17Speaker 1: Yeah.
- 40:18Speaker 3: So there are several approaches. There are pharmacological approaches. So
- 40:23Speaker 3: for example, with opioid addiction, a frontline medication is naloxone.
- 40:29Speaker 3: And that's an inhibitor. It binds to the receptor and
- 40:32Speaker 3: it blocks the opioid from being able to hit the receptor.
- 40:35Speaker 3: And so you can prevent someone from ODing. You can
- 40:38Speaker 3: rescue their breathing. That's why it's a frontline defense. But
- 40:42Speaker 3: then longer treatment, there's buprenorphine and methadone, which also hit
- 40:47Speaker 3: those receptors. They give a little bit of the euphoria,
- 40:51Speaker 3: but they're much, much safer. And so other countries use
- 40:54Speaker 3: those much more than the United States for treatment of
- 40:57Speaker 3: opioid addiction. Things like cocaine, there's almost nothing out there
- 41:02Speaker 3: for cocaine. People are trying to use your own immune
- 41:06Speaker 3: system to fight cocaine use disorder and methamphetamine use disorder,
- 41:11Speaker 3: where you can get your immune system to create antibodies
- 41:14Speaker 3: against the drug, and then the drug can't bind the
- 41:17Speaker 3: receptor or the transporter or whatever, whatever its mode of
- 41:20Speaker 3: action is. So that's been somewhat successful. People are using
- 41:26Speaker 3: electromagnetic stimulation in the brain. That's been successful for like
- 41:30Speaker 3: antidepressant resistant depression. And it works in addiction in some areas.
- 41:36Speaker 4: Wait, are you talking about like zapping people's brains?
- 41:39Speaker 3: Yeah.
- 41:40Speaker 5: Wow.
- 41:41Speaker 4: And my, again, very limited understanding is that we don't
- 41:44Speaker 4: really understand why that works. It's just kind of like
- 41:46Speaker 4: a thing we've tried on people and we've seen that
- 41:49Speaker 4: it kind of does work. Or do we understand why
- 41:52Speaker 4: applying electric shocks to the brain can help in this situation?
- 41:54Speaker 3: I don't know enough about that area. I'd be afraid
- 41:57Speaker 3: to speculate too much on the mode of action, how
- 42:01Speaker 3: it works, how persistent it works. That's what I would
- 42:04Speaker 3: want to know. We can see short-term effects, but how
- 42:07Speaker 3: do those short-term effects really translate into long-term? did that
- 42:11Speaker 3: one or very specific dosing of electromagnetic stimulation cause long-term
- 42:18Speaker 3: effects or was it just temporary? I can totally see
- 42:21Speaker 3: a mechanism for temporary. I don't understand exactly how it'd
- 42:24Speaker 3: be specific for long-term, but maybe that's known. I don't know. Okay.
- 42:28Speaker 2: So electromagnetic stimulation, I think there was at least one
- 42:31Speaker 2: more thing you were going to tell us about.
- 42:33Speaker 4: Chocolate therapy. Wasn't it chocolate therapy?
- 42:36Speaker 3: Oh yeah. Sorry. That, that was actually the, the, um,
- 42:39Speaker 3: Cardiobehavioral therapy. So using social groups, social support, those are huge.
- 42:44Speaker 3: And then there's also, and this is controversial in the
- 42:47Speaker 3: United States, but using monetary reward in place of drug
- 42:53Speaker 3: to stay clean.
- 42:54Speaker 4: Wow.
- 42:54Speaker 3: And that kind of management works extremely well.
- 42:57Speaker 4: Paying people not to take drugs.
- 42:59Speaker 3: Exactly. And you can just saying it makes you understand
- 43:03Speaker 3: why a lot of people are against it.
- 43:07Speaker 2: I can imagine if you factor in the cost of
- 43:09Speaker 2: supporting somebody with an addiction, if you could just give
- 43:12Speaker 2: them that money and they'd stop, that might be better
- 43:14Speaker 2: for everybody.
- 43:15Speaker 3: Right. No, the money's peanuts to run those programs compared
- 43:18Speaker 3: to the over $ 1 to $ 4 trillion that costs just
- 43:22Speaker 3: the United States to deal with addiction.
- 43:23Speaker 4: Wow.
- 43:24Speaker 1: A year.
- 43:25Speaker 4: Well, it's a similar argument for like universal basic income
- 43:28Speaker 4: or universal health care. Preventative costs are always smaller.
- 43:32Speaker 3: Exactly.
- 43:33Speaker 2: Well, our listeners had questions about coffee and sugar and
- 43:37Speaker 2: a couple other addictive stimulants.
- 43:39Speaker 1: And so let's take a break. And when we come back,
- 43:41Speaker 1: we'll get to their questions. All right, we're back.
- 44:03Speaker 2: And so one thing that I'm dying to know is
- 44:05Speaker 2: we've been talking about drugs of abuse, but how do
- 44:08Speaker 2: drugs of abuse differ from something like my addiction to
- 44:12Speaker 2: scrolling on Instagram or.
- 44:14Speaker 1: My addiction to coffee in the morning or Daniel's?
- 44:17Speaker 2: Massive addiction that's apparently all he thinks about to chocolate.
- 44:22Speaker 4: You mean very healthy habit-forming behavior.
- 44:24Speaker 1: That's right, yes.
- 44:26Speaker 3: Yeah, so, and this, I won't probably speak too much
- 44:30Speaker 3: because I don't know enough about natural things like sugar, etc.
- 44:36Speaker 3: Drugs of abuse have an absolutely outscaled effect on the
- 44:39Speaker 3: neurotransmitter systems and the circuitry in the brain. Things like sugar,
- 44:44Speaker 3: people say, oh, you become addicted to sugar. And we
- 44:47Speaker 3: continuously escalate our sugar intake. And yeah, sugar is a
- 44:51Speaker 3: problem in our American diet. But the impact on metabolism
- 44:57Speaker 3: as a whole is massive. And so trying to then
- 45:01Speaker 3: parse out, okay, what changed in the whole milieu of
- 45:06Speaker 3: metabolism from increasing sugar and compulsive sugar intake that led
- 45:12Speaker 3: to more is really hard to pinpoint. Other things like gambling,
- 45:18Speaker 3: Social media, there was a huge lawsuit that I think
- 45:22Speaker 3: Meta just lost for social media and trapping adolescents into
- 45:28Speaker 3: social media addiction, right? So there must be aspects of
- 45:33Speaker 3: that that are true. It's definitely true for gambling. These things,
- 45:37Speaker 3: social media, gambling, they also release that neurotransmitter. And one
- 45:42Speaker 3: reason is because of something called prediction error. So dopamine
- 45:46Speaker 3: in your brain, is not really thought of as, oh,
- 45:49Speaker 3: it's a pleasurable molecule, the pleasure molecule. People mislabel it
- 45:53Speaker 3: that way. Oh, you had this amazing meal. We released
- 45:57Speaker 3: all this dopamine. That's why it tastes so good. That's
- 46:01Speaker 3: not really it. It's the increase in dopamine is a
- 46:04Speaker 3: motivation seeker. It tells us and motivates us to go
- 46:08Speaker 3: get it. And so with gambling and social media, The
- 46:14Speaker 3: dopamine is acting as a prediction error in that you
- 46:18Speaker 3: got a better than expected reward. And so for gambling,
- 46:21Speaker 3: you know you're going to lose a lot. But every
- 46:24Speaker 3: once in a while, you're going to hit.
- 46:25Speaker 5: Yeah.
- 46:26Speaker 3: And when you hit, that high is awesome because your
- 46:28Speaker 3: prediction error, you kept expecting, you know, lose, lose, lose, lose.
- 46:33Speaker 3: But when you hit and you hit big, it's a
- 46:36Speaker 3: massive bonus, like, ah, dopamine, so much release. It's going
- 46:40Speaker 3: to drive us to go do that again because it
- 46:42Speaker 3: was great. It was a great experience, right? Social media,
- 46:47Speaker 3: when people post something that goes viral, same thing. All
- 46:51Speaker 3: of a sudden, attention, people saying great things about you, blah, blah, blah,
- 46:56Speaker 3: and people get addicted to that and keep pursuing it.
- 46:59Speaker 3: And that can be very detrimental, especially in teenagers. where
- 47:04Speaker 3: the whole reward circuitry, the learning and memory circuitry in
- 47:08Speaker 3: a teenager is still evolving. There's a very complex hormonal
- 47:12Speaker 3: kind of control of how the brain is continuing to
- 47:15Speaker 3: develop during adolescence. And that's when we're hitting all these
- 47:20Speaker 3: kids with pretty bad diets in some cases, social media constantly.
- 47:28Speaker 3: All the news people see is fantastical and blown out
- 47:32Speaker 3: of proportion. and clickbait, right? It's either amazingly incredible or
- 47:38Speaker 3: it's horrific and world destroying, right? That's how our media
- 47:42Speaker 3: is pitched to us now so that we'll actually click
- 47:45Speaker 3: on it. And so, when the brain starts to see
- 47:47Speaker 3: all of this, it gets confused. The neurotransmitter, all it
- 47:51Speaker 3: is is a prediction error. It can't assess value of
- 47:55Speaker 3: what you're looking at and what you're doing, really, right?
- 47:58Speaker 3: And that's where all those social constructs, psychosocial behavior, your
- 48:02Speaker 3: support group, your family, your friends, that's where all that
- 48:05Speaker 3: becomes really, really important. It helps your brain and that
- 48:09Speaker 3: collection of brains figure out how to respond to these things.
- 48:13Speaker 2: Wow.
- 48:13Speaker 4: So when you say the dopamine is the prediction error
- 48:16Speaker 4: and that it's not like the reward, It's the thing
- 48:19Speaker 4: that motivates you to go back and like put down
- 48:22Speaker 4: another 20 bucks on blackjack.
- 48:24Speaker 3: Yeah.
- 48:24Speaker 4: Because it's anticipating the occasional big hit.
- 48:28Speaker 3: Right.
- 48:29Speaker 5: I see.
- 48:29Speaker 3: And then we keep pursuing that big hit. Yeah. And
- 48:33Speaker 3: it's the same thing that thrill seekers do, extreme skiing.
- 48:37Speaker 3: I grew up doing extreme skiing.
- 48:39Speaker 4: Cool.
- 48:40Speaker 3: And I just kept looking for that bigger cliff, more
- 48:44Speaker 3: inclined just to get that rush. And you start pursuing
- 48:47Speaker 3: more and more dangerous things until you start breaking bones.
- 48:50Speaker 3: And then you get either too old or you stop
- 48:54Speaker 3: or you die.
- 48:54Speaker 2: I am way less exciting. For me, the big hit
- 49:00Speaker 2: is when a goat post comes up on Instagram.
- 49:02Speaker 1: And I'm like, goats! That's what's exciting for me. But
- 49:07Speaker 1: I stay here. Did you break bones?
- 49:10Speaker 3: I got pretty lucky. But I'm 54 years old right now,
- 49:15Speaker 3: and I damaged my MCL in January. I hit a
- 49:18Speaker 3: tree in March. Oh. but I still love to ski.
- 49:21Speaker 3: So it's all good. Good luck. You learn how to fall.
- 49:27Speaker 4: So maybe that's a good transition to studies of how
- 49:31Speaker 4: we avoid or leave addictive behaviors. So when Marcelo has
- 49:36Speaker 4: been skiing and getting that fix of that thrill of like, wow,
- 49:39Speaker 4: I just did something stupid and survived, and then you
- 49:42Speaker 4: stop doing it. You were talking earlier about the basic
- 49:45Speaker 4: mechanisms of addiction involve obviously the reward and then the
- 49:49Speaker 4: habit formation, but then the sort of desensitivity to it.
- 49:52Speaker 4: Is it that last part that's crucial for the difficulty
- 49:56Speaker 4: of leaving the addictive behavior?
- 49:59Speaker 3: Yeah, I think as the brain kind of switches to
- 50:01Speaker 3: this compulsive approach, it's battling, one, the anhedonia, the lack
- 50:08Speaker 3: of reward for natural rewards and the normal things that
- 50:11Speaker 3: you do that should be pleasurable, like the goats, right?
- 50:15Speaker 3: That's a natural, normal thing that should be fun.
- 50:18Speaker 1: That's right.
- 50:19Speaker 3: And I don't know what's wrong with people that don't
- 50:21Speaker 3: like goats.
- 50:21Speaker 4: Obvious evolutionary benefits.
- 50:26Speaker 1: There are some crazy people out there.
- 50:28Speaker 3: Yeah, yeah. So your brain starts to battle that. And
- 50:32Speaker 3: then your brain has also changed the levels of receptors
- 50:37Speaker 3: and all these compensatory things that lead to tolerance and sensitization.
- 50:42Speaker 3: incubation of craving. The longer you're away from something, the
- 50:45Speaker 3: more you crave it. That's a wild mechanism. And so
- 50:49Speaker 3: it really becomes important trying to find how you normalize
- 50:52Speaker 3: those things. How do you get back to normal rewards
- 50:56Speaker 3: being stimulating again? And time and time again, one of
- 51:01Speaker 3: the most important things is social interaction. That means more
- 51:05Speaker 3: to your brain than most other things. But it gets
- 51:10Speaker 3: harder and harder for us to do that. So like,
- 51:11Speaker 3: for example, in the pandemic, addiction and overdose deaths skyrocketed.
- 51:17Speaker 4: Wow.
- 51:18Speaker 3: Because we were isolated. We're socially isolated. So it was
- 51:21Speaker 3: a very scary problem when thinking about addiction. Now that
- 51:24Speaker 3: things have normalized a bit more, it's gotten better. But
- 51:28Speaker 3: this is also one of the concerns about our online
- 51:31Speaker 3: lives and how fake our online lives can be. It
- 51:35Speaker 3: all comes back down to Trying to find normal pleasures
- 51:40Speaker 3: would be rewarding. And can you maintain that? And for
- 51:44Speaker 3: some people, that's exercise. Exercise is great. Getting into that
- 51:47Speaker 3: habitual exercise starts to re-transform how your brain responds. And
- 51:52Speaker 3: exercise affects all the epigenetic machinery as well. It affects
- 51:56Speaker 3: how your metabolism reacts. And so you can use those
- 51:58Speaker 3: things to help modify.
- 52:01Speaker 4: And so somebody who's become addicted to coffee in the
- 52:03Speaker 4: morning and then stops coffee and gets headaches, Your advice is,
- 52:08Speaker 4: even though you don't feel like going to speak to
- 52:10Speaker 4: anybody now because you're miserable, what you really should do
- 52:13Speaker 4: is go talk to your neighbors. Yes.
- 52:17Speaker 3: Although coffee and headaches are a bit different mechanism.
- 52:22Speaker 2: Do we understand that mechanism? Because I think our listener
- 52:25Speaker 2: wanted to know why they get a headache when they
- 52:27Speaker 2: try to wean themselves off coffee.
- 52:29Speaker 3: Yeah, I remember looking this up a long time ago.
- 52:31Speaker 3: I don't quite remember, but it does have to do
- 52:33Speaker 3: with vasoconstriction and caffeine and vasoconstriction. But I can't remember
- 52:37Speaker 3: the exact mechanism.
- 52:38Speaker 1: Okay.
- 52:39Speaker 3: So when you're not having your coffee at the right time,
- 52:43Speaker 3: miss it by a couple hours, you start to get
- 52:45Speaker 3: a headache. It's because the blood pressure in your brain
- 52:47Speaker 3: has changed.
- 52:47Speaker 4: That makes sense.
- 52:50Speaker 2: It feels all the more imperative then to get coffee
- 52:53Speaker 2: if you're like, oh my gosh, the pressure in my
- 52:55Speaker 2: brain is increasing.
- 52:56Speaker 1: I need to go get coffee. And so now I
- 52:59Speaker 1: will never be late for my coffee again.
- 53:00Speaker 4: Yep. What do you think is the future of this field?
- 53:04Speaker 4: What do you think we're going to be able to
- 53:06Speaker 4: do in 15 or 30 years that we can't do
- 53:08Speaker 4: today to help people with addiction?
- 53:10Speaker 3: Yeah, so I think two or three things might be incredible.
- 53:15Speaker 3: One is trying to understand who will develop addiction and
- 53:19Speaker 3: who will not. How do you help people self-identify that
- 53:25Speaker 3: they have the genetics or the behavioral psychosocial environment where
- 53:31Speaker 3: they really are much more high at risk and to
- 53:34Speaker 3: be educated in that. Education goes a long way in addiction.
- 53:39Speaker 3: Two is for things like epilepsy, there are some incredible
- 53:45Speaker 3: closed loop circuit devices that as soon as someone's like
- 53:50Speaker 3: hippocampus is about to have a seizure, the device starts
- 53:53Speaker 3: to register the neuronal spiking and then dampen it down
- 53:56Speaker 3: so the person doesn't seize. And so as we identified
- 54:00Speaker 3: the reward, circuitry that triggers relapse and the cell types
- 54:05Speaker 3: and the firing patterns, those types of mechanisms could theoretically
- 54:09Speaker 3: be used so that as someone's brain starts to trigger relapse,
- 54:13Speaker 3: that device shuts it down and prevents it.
- 54:15Speaker 4: Wow.
- 54:16Speaker 3: And then the third, science fiction, but this is working
- 54:20Speaker 3: in other domains, is.
- 54:21Speaker 4: Robotic goats?
- 54:23Speaker 5: No.
- 54:23Speaker 4: Okay.
- 54:25Speaker 3: CRISPR editing. And so we now know, for example, in
- 54:28Speaker 3: sickle cell anemia, you can do CRISPR editing and It's
- 54:32Speaker 3: quite successful.
- 54:33Speaker 4: So you mean changing people's genes, basically gene therapy?
- 54:36Speaker 5: Right.
- 54:36Speaker 4: Wow.
- 54:37Speaker 3: It's in vivo gene therapy within the organism. And there
- 54:41Speaker 3: are ways that that is starting to evolve dramatically in science.
- 54:45Speaker 3: And so is that a future for addiction therapy? Maybe not.
- 54:50Speaker 3: But like you said, it's 15, 20, 30 years out there.
- 54:54Speaker 4: I can't see any way that could ever go wrong.
- 54:57Speaker 4: So that sounds great. No, never, never.
- 55:01Speaker 2: I like it when you're the wet blanket, Daniel. It's
- 55:03Speaker 2: usually my job. It's very refreshing when you take up
- 55:07Speaker 2: the torch.
- 55:09Speaker 5: All right.
- 55:10Speaker 2: Well, Marcelo, thank you very much for being on the show.
- 55:12Speaker 2: I had a ton of fun. Thank you for putting
- 55:14Speaker 2: up with living next to Daniel. That must be a
- 55:17Speaker 2: lot of fun. A real roller coaster. And I assume
- 55:20Speaker 2: whenever there's a problem.
- 55:21Speaker 3: Now I know where I can get my chocolate.
- 55:22Speaker 4: That's right.
- 55:23Speaker 3: Yeah.
- 55:23Speaker 2: I was going to say, I assume whenever there's like
- 55:24Speaker 2: a neighborhood level problem, if you just bring Daniel enough chocolate,
- 55:27Speaker 2: he'll get on your side.
- 55:29Speaker 4: That's a bean. That counts as a bean.
- 55:31Speaker 3: That's right.
- 55:32Speaker 1: Okay.
- 55:33Speaker 3: All right.
- 55:33Speaker 1: Well, thank you very much for joining us.
- 55:35Speaker 4: All right. Appreciate it. Thanks, Marcelo.
- 55:37Speaker 3: That was wonderful. Thank you. Whoa. That was super interesting.
- 55:40Speaker 5: I'd never heard of the epigenome before. So, understanding how
- 55:45Speaker 5: the human body becomes accustomed to drugs makes sense in
- 55:48Speaker 5: that context, but I still don't think I understand the
- 55:51Speaker 5: withdrawal part of my question. If I don't drink coffee,
- 55:54Speaker 5: my withdrawal symptom is a headache. If a person addicted
- 55:57Speaker 5: to a more serious drug abstains, then they could experience
- 55:59Speaker 5: significantly more extreme effects than a headache. I'd love to
- 56:03Speaker 5: understand what's causing that. Phrased differently, why, as a coffee drinker,
- 56:07Speaker 5: does my brain's blood pressure change and give me a
- 56:10Speaker 5: headache if I skip caffeine for the day? Thank you, Daniel, Kelly,
- 56:14Speaker 5: and Dr. Marcelo Sweetwater-Wood for an incredible episode. What a
- 56:18Speaker 5: great deep dive into a fascinating topic.
- 56:21Speaker 3: Yeah, I listened to the episode.
- 56:22Speaker 6: It seems that nobody's addicted to sugar, and it's just
- 56:26Speaker 6: a habit that is a strong habit. Not quite sure
- 56:30Speaker 6: where the dividing line between addiction and a strong habit
- 56:33Speaker 6: would be. But as a follow-up question, I wonder if
- 56:37Speaker 6: the addiction or strong habit to ketones might be anorexia.
- 56:41Speaker 3: I don't know. Anyway, very interesting episode. Thank you very much. Cheers.
- 56:46Speaker 4: Bye-bye. Thanks everybody for listening. Please go and do us
- 56:56Speaker 4: a favor and rate the show on whatever podcast app
- 56:59Speaker 4: you're using. It really helps people find us.
- 57:01Speaker 2: Daniel and Kelly's Extraordinary Universe is edited by the amazing
- 57:05Speaker 2: Matt Kesselman.
- 57:06Speaker 4: He really is a wizard. You can also find us
- 57:10Speaker 4: online on Blue Sky, Instagram, and X, D & K Universe.
- 57:15Speaker 4: Come engage with us.
- 57:16Speaker 2: You can email us at questions at DanielAndKelly.org. We really
- 57:20Speaker 2: do want to hear from you.
- 57:21Speaker 4: And you can find our website, www.DanielAndKelly.org. where you'll also
- 57:27Speaker 4: find an invitation to join our Discord, where everybody comes
- 57:30Speaker 4: and talks about the amazing universe.
- 57:33Speaker 2: And we also have the most amazing moderators. This is
- 57:37Speaker 2: an iHeart podcast. Thanks for joining us.